PTC Therapeutics (PTCT) Institutional Ownership

Of the 312 institutional investors that purchased PTC Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Toronto Dominion Bank ($7.47M), Janus Henderson Group PLC ($3.88M), State Street Corp ($1.76M), Jefferies Financial Group Inc. ($1.66M), Driehaus Capital Management LLC ($1.51M), Point72 Asset Management L.P. ($1.51M), and Nuveen LLC ($1.01M).

Institutional investors have bought a total of 23,139,515 shares in the last 24 months. This purchase volume represents approximately $1.55B in transactions.

Of the 136 institutional investors that sold PTC Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Wolverine Asset Management LLC ($40.36M), Millennium Management LLC ($5.36M), Armistice Capital LLC ($2.63M), Wellington Management Group LLP ($1.05M), Man Group plc ($655.33K), Marshall Wace LLP ($583.26K), and Assenagon Asset Management S.A. ($577.45K).

Institutional investors have sold a total of 56,822,960 shares in the last 24 months. This volume of shares sold represents approximately $3.05B in transactions.